SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following a post-earnings decline triggered by soft revenue guidance and disappointing services growth, despite posting record quarterly figures. The community is actively debating whether the dip represents a buying opportunity for a long-term hold or a sign of deeper structural weakness, with significant discussion focused on the impact of rising memory costs and supply chain constraints.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon surged after reporting accelerating cloud growth and record-breaking revenue figures that underscored the tangible returns on its massive artificial intelligence investments. Investors are closely scrutinizing the company's aggressive capital expenditure plans as a key indicator of long-term AI demand, with sentiment remaining bullish as the community debates the sustainability of current AI infrastructure spending versus the scale of the company's backlog.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit shares experienced a sharp decline following its latest quarterly report, as investors reacted negatively to commentary regarding volatile search referral traffic and a sequential dip in U.S. daily active users. While the community remains divided between long-term bulls highlighting strong revenue growth and critics concerned about management's communication and platform moderation, many traders are discussing whether this sell-off provides a prime buying opportunity for a business with high margins and significant AI licensing potential.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is navigating market volatility following a failed late-stage trial for its experimental heart drug, ziltivekimab, though the community remains divided between those viewing the pullback as a buying opportunity and others worried about pipeline reliability. Investors are actively debating whether this decline is an overreaction that ignores the continued strength of core assets like Wegovy and Ozempic, while closely watching for potential M&A activity to bolster the long-term pipeline.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is experiencing significant downward pressure as investors grapple with disappointing earnings guidance and multiple analyst downgrades, fueling concerns over a potential lifecycle decline. The community remains deeply polarized, with bears focusing on the platform's user monetization headwinds and ethical controversies, while bulls continue to debate the stock's valuation and the timing of a long-term turnaround.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is trending following a massive Q2 earnings beat and a long-term supply agreement with Lumentum that bolsters its position in the AI data center supply chain. While the community is actively debating the company's ability to navigate export permit risks and structural complexity, sentiment remains polarized between bulls targeting a long-term squeeze and bears highlighting overvaluation concerns.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is facing significant volatility following a weak quarterly earnings report that missed analyst expectations and triggered a wave of price target cuts. While bears point to the revenue miss and regulatory uncertainty surrounding the Clarity Act as reasons to stay away, retail sentiment is split, with some bulls viewing the drop as a long-term buying opportunity as the company shifts focus toward subscription and service-based revenue.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon Mobil is currently the subject of intense investor attention as volatility in the Middle East, specifically surrounding the Strait of Hormuz, keeps energy markets hyper-focused on supply disruptions and potential geopolitical catalysts. The community is actively debating whether energy valuations have already priced in a resolution to conflict, with many traders analyzing the stock as both a hedge against geopolitical instability and a play on long-term structural demand for oil and gas.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is trending as investors weigh strong operational results, including record U.S. production and a significant 20-year power agreement with Microsoft to fuel AI data centers, against volatile energy markets impacted by Middle East tensions. Community sentiment is deeply divided, with many traders debating whether to capitalize on the stock's robust cash flow and dividends or to exit due to concerns over high valuations and broader energy sector uncertainty.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as investors weigh its aggressive M&A strategy, exemplified by the acquisition of Apogee Therapeutics, against market concerns over competitive pressure on its immunology portfolio and the potential for slowing growth in key assets. Community sentiment is mixed, with some highlighting the company's strong dividend and defensive characteristics as a sector hedge, while others debate whether recent deal premiums and patent-cliff risks justify current valuation levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

 VKTX Stock Lags GLP-1 Peers In July — But Viking CEO Says Its Obesity Drug Could Offer What Rivals Can’t 

Equity

Viking expects oral VK2735 Phase 3 studies to begin in Q4 and believes the pill could become the first oral dual GLP-1 agonist to reach the market.

ALT Stock Reverses Early Gains On Positive Alcohol Use Trial — But Wall Street, Retail Investors Dismiss Selloff

Earlier on Tuesday, Altimmune said the mid-stage RECLAIM trial met its main goal and key secondary goals.


Altimmune’s Investigational Therapy For Alcohol Use Disorder Meets Primary Endpoint – ALT Stock Jumps 10%

Altimmune’s Phase 2 trial showed Pemvidutide reduced heavy drinking by 4.20 days per week compared with the placebo’s 2.75 days.


Altimmune Scores Major Phase 2 Win in Alcohol Use Disorder, Strengthening the Case for Pemvidutide's Multi-Billion-Dollar Potential

Altimmune (NASDAQ:ALT) delivered one of its most significant clinical milestones to date, reporting positive topline results from its RECLAIM Phase 2 trial evaluating pemvidutide in patients with moderate to severe alcohol use disorder (AUD). The investigational dual glucagon/GLP-1 receptor agonist met the study's primary endpoint, producing a statistically significant reduction in heavy drinking days compared with placebo while also achieving multiple important secondary endpoints recognized by the U.S. Food and Drug Administration (FDA) as potential registrational measures.

Leerink Sees Altimmune (ALT) As An Attractive Play In The MASH Therapeutics Market

Leerink Sees Altimmune (ALT) As An Attractive Play In The MASH Therapeutics Market...

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker 

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook article.


5 Small Drug Stocks to Invest in Amid a Biotech Comeback

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may prove to be good additions to one's portfolio.

Why Is Altimmune (ALT) Down 11.3% Since Last Earnings Report?

Altimmune (ALT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ALT and the Rise of Dual Agonists Targeting Liver Disease

Altimmune's dual-agonist pemvidutide faces key 2026 tests in MASH and alcohol-related diseases that could validate its multi-pathway liver strategy.

ALT Stock Guide to Pemvidutide's MASH, AUD and ALD Setup

Altimmune is betting on pemvidutide across MASH and alcohol-related liver diseases, with key 2026 data and a planned Phase III launch shaping its path.

$ALT Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of -$0.18 up 30.77% YoY
• Altimmune expects to initiate its global PERFORMA Phase 3 MASH trial in the second half of 2026. Topline data from the RECLAIM Phase 2 AUD trial is expected in the third quarter 2026.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. Its lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are emphasizing that robust Phase 2 AUD clinical results significantly de-risk the company's entire metabolic drug platform.

Persistent speculation surrounds potential big pharma interest, with many hoping for a high-value buyout of the promising pipeline assets.

Traders are intensely debating whether high volume, low price volatility, and short selling suggest sophisticated institutional market manipulation.

High anticipation is building for the upcoming Q2 earnings call and potential news regarding the MASH Phase 3 trial initiation.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ALTAltimmune Inc

Latest ALT News